Business Wire

SignPath Pharma Reports Extremely Beneficial Blood Level Results of Its Phase 1b Clinical Trials of Liposomal Curcumin in Advanced Cancer Patients as Published in the Cancer ...

SALT LAKE CITY--(BUSINESS WIRE)--SignPath Pharma Inc. reported in the October issue of “Cancer Chemotherapy and Pharmacology”*, a leading cancer journal, the final results of a Phase 1b cancer study ...
Business Wire

Multiple Myeloma-Causing Plasma Cells Show Intense Uptake of Intravenous Liposomal Curcumin as Reported by SignPath Pharma, Inc. in Paper Published in the Cancer Research ...

SALT LAKE CITY--(BUSINESS WIRE)--SignPath Pharma, Inc. reported in the March issue of Anticancer Research* that its proprietary intravenous liposomal curcumin (LipoCurc™) concentrates very intensely ...
EurekAlert!

Trial targets deadly lung cancer

With more than 650 Australians diagnosed with malignant mesothelioma last year, Flinders University is leading new research to discover alternatives to chemotherapy and even prevent deaths by early ...
Rolling Out

Turmeric’s secret power that science won’t tell you

Turmeric, derived from the Curcuma longa plant, has been a staple in traditional medicine for centuries. But its transition from an ancient remedy to a widely studied health supplement marks a shift ...